Copyright
©The Author(s) 2017.
World J Gastroenterol. Sep 28, 2017; 23(36): 6628-6638
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6628
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6628
Glucocorticoids | Component | Indications | Ref. |
1st generation | Prednisone | Moderate to Severe cases | [3,25,27] |
Methyl-Prednisolone | of IBDs | [26] | |
Hydrocortisone | Short duration of treatment | [29] | |
2nd generation | Budesonide | Moderate CD cases | [32-34] |
Budesonide MMX | Mild to moderate UC cases | [36,37] | |
Beclomethasone dipropionate | Topical administration | [40,41] | |
Erythrocyte - Mediated Delivery of Dexamethasone | In research for long term treatments | [42] |
- Citation: Dubois-Camacho K, Ottum PA, Franco-Muñoz D, De la Fuente M, Torres-Riquelme A, Díaz-Jiménez D, Olivares-Morales M, Astudillo G, Quera R, Hermoso MA. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology. World J Gastroenterol 2017; 23(36): 6628-6638
- URL: https://www.wjgnet.com/1007-9327/full/v23/i36/6628.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i36.6628